This website is intended for UK healthcare professionals only

Webinars
and Events

BOPA 2021: A practical look at service optimisation in non-metastatic castration-resistant (nmCRPC) prostate cancer

Description

 

The Bayer sponsored video at the British Oncology Pharmacy Association 24th Annual Symposium was hosted by Simon Shepherd, Pharmacist, Engagement & Educational Manager – Oncology, Bayer, who interviewed Robert Duncombe, Chief Pharmacist, The Royal Marsden and Junaid Mobeen, Specialist Clinical Pharmacist Practitioner, Nottingham University Hospital. This discussion focussed on the evolving treatment landscape in nmCRPC, and the role of the pharmacist in the management of nmCRPC patients including how the role of the pharmacist can be extended to address capacity issues within the NHS.

 

Video title

YYMMDD Author/Uploaded by

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.


Speakers

Robert Duncombe

Robert Duncombe

Rob Duncombe is the Clinical Director of Pharmacy at the Royal Marsden in London and chair of the Royal Pharmaceutical Society Hospital Expert Advisory Group. He is an experienced hospital pharmacist and chief of pharmacy in the NHS, having previously worked as the director of pharmacy at The Christie NHS Foundation trust and worked for seven years as chief pharmacist at the Princess Alexandra hospital in Harlow, Essex.

Junaid Mobeen

Junaid Mobeen

Junaid Mobeen is the Lead Oncology Pharmacist at Nottingham University Hospitals and runs a pharmacy-led service for prostate cancer patients including remote patient monitoring.

BAUN 2021: Identifying, managing and treating nmCRPC patients

BAUN 2021: Identifying, managing and treating nmCRPC patients

Be informed of future content relevant to you

Be informed of future content relevant to you

Opt-in to Bayer
communications

Want to stay in touch?

If you would like us to keep you up to date with details of future webinars and other important news updates, please stay connected using the button below.

OPT-IN TO BAYER COMMUNICATIONS OPT-IN TO BAYER COMMUNICATIONS

Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Bayer plc Tel: 01182 063 500, Fax: 01182 063 703, Email: pvuk@bayer.com.

 

If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc Email: qualitycomplaints@bayer.com For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.